(Q40645395)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

New selective ligands of human cloned melatonin MT1 and MT2 receptors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

0 references

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

11

Benoît Malpaux

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Valérie Audinot

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

François Mailliet

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Chantal Lahaye-Brasseur

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Anne Bonnaud

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Aude Le Gall

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Christophe Amossé

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sandra Dromaint

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Marianne Rodriguez

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Nadine Nagel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Jean-Pierre Galizzi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Gérald Guillaumet

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Daniel Lesieur

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

François Lefoulon

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Pierre Renard

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Philippe Delagrange

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

23 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

Naunyn-Schmiedeberg's Archives of Pharmacology

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

553-561

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764576%20AND%20SRC:MED&resulttype=core&format=json

Melatonin analogues as agonists and antagonists in the circadian system and other brain areas.

3 November 2019

cites work

1 reference

12 December 2020

Substituted oxygenated heterocycles and thio-analogues: synthesis and biological evaluation as melatonin ligands

1 reference

12 December 2020

Studies on the vasoconstrictor action of melatonin and putative melatonin receptor ligands in the tail artery of juvenile Wistar rats.

1 reference

12 December 2020

Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses

1 reference

12 December 2020

The effects of saponin on the binding and functional properties of the human adenosine A1 receptor

1 reference

12 December 2020

Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands

1 reference

12 December 2020

Differential signaling of human Mel1a and Mel1b melatonin receptors through the cyclic guanosine 3'-5'-monophosphate pathway

1 reference

12 December 2020

Synthesis of a small library of phenylalkylamide derivatives as melatoninergic ligands for human mt1 and MT2 receptors.

1 reference

12 December 2020

Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor

1 reference

12 December 2020

Melatonin receptors mediate contraction of a rat cerebral artery

1 reference

12 December 2020

Characterisation of human melatonin mt(1) and MT(2) receptors by CRE-luciferase reporter assay

1 reference

12 December 2020

Ligand modulation of [35S]GTPgammaS binding at human alpha(2A), alpha(2B) and alpha(2C) adrenoceptors

1 reference

12 December 2020

Comparison of the structure-activity relationships of melatonin receptor agonists and antagonists: lengthening the N-acyl side-chain has differing effects on potency on Xenopus melanophores

1 reference

12 December 2020

Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms

1 reference

12 December 2020

Antagonistic effects of S 22153, a new mt1 and MT2 receptor ligand, on the neophobia-reducing properties of melatonin in BALB/c mice.

1 reference

12 December 2020

Melatonin and adjustment to phase shift

1 reference

12 December 2020

Design and synthesis of new naphthalenic derivatives as ligands for 2-[125I]iodomelatonin binding sites

1 reference

12 December 2020

A single oral dose of S 22153, a melatonin antagonist, blocks the phase advancing effects of melatonin in C3H mice

1 reference

12 December 2020

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

12 December 2020

Inverse agonism and constitutive activity as functional correlates of serotonin h5-HT(1B) receptor/G-protein stoichiometry

1 reference

12 December 2020

Synthesis and structure-affinity-activity relationships of novel benzofuran derivatives as MT(2) melatonin receptor selective ligands

1 reference

12 December 2020

Constitutive activity at serotonin 5-HT(1D) receptors: detection by homologous GTPgammaS versus [(35)S]-GTPgammaS binding isotherms.

1 reference

12 December 2020

Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands

1 reference

12 December 2020

Synthesis of phenalene and acenaphthene derivatives as new conformationally restricted ligands for melatonin receptors

1 reference

12 December 2020

Tetrahydronaphthalenic derivatives as new agonist and antagonist ligands for melatonin receptors

1 reference

12 December 2020

Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists

1 reference

12 December 2020

Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor

1 reference

12 December 2020

2-N-acylaminoalkylindoles: design and quantitative structure-activity relationship studies leading to MT2-selective melatonin antagonists

1 reference

12 December 2020

Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT(3).

1 reference

12 December 2020

Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2 .

1 reference

12 December 2020

Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors.

1 reference

12 December 2020

Melatonergic properties of the (+)- and (-)-enantiomers of N-(4-methoxy-2,3-dihydro-1H-phenalen-2-yl)amide derivatives

1 reference

12 December 2020

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

12 December 2020

Design of subtype selective melatonin receptor agonists and antagonists

1 reference

12 December 2020

Identification of the melatonin-binding site MT3 as the quinone reductase 2.

1 reference

12 December 2020

Novel naphthalenic ligands with high affinity for the melatonin receptor

1 reference

12 December 2020

Pharmacological characterization of human recombinant melatonin mt(1) and MT(2) receptors

1 reference

12 December 2020

Structure-activity relationship studies of melanin-concentrating hormone (MCH)-related peptide ligands at SLC-1, the human MCH receptor

1 reference

12 December 2020

Pineal Melatonin: Cell Biology of Its Synthesis and of Its Physiological Interactions*

1 reference

12 December 2020

A new melatonin receptor ligand with mt1-agonist and MT2-antagonist properties.

1 reference

12 December 2020

Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles

1 reference

12 December 2020